Form 4: HCA Healthcare SVP & Controller Sells Shares
Insider Transaction Report
HCA Healthcare's SVP & Controller, Christopher F. Wyatt, reported the vesting of performance share units and subsequent sale of common stock.
Summary
- Christopher F. Wyatt, SVP & Controller of HCA Healthcare, acquired 3,350 shares of common stock on February 10, 2026, at a price of $0 per share, resulting from the vesting of performance share units.
- The performance share units, granted on January 30, 2023, vested at 200% of the original 1,675 units granted, based on the company's achievement of its cumulative earnings per share goal for fiscal years 2023-2025.
- On February 10, 2026, 1,034 shares were disposed of at $502.05 per share to cover tax withholding obligations related to the vesting.
- An additional 4,000 shares of common stock were sold on February 11, 2026, at a price of $505 per share.
- Following these transactions, Christopher F. Wyatt beneficially owns 44,379 shares of HCA Healthcare common stock.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as positive for HCA Healthcare's operational performance, as evidenced by the 200% vesting of performance share units, though the subsequent insider sale is a common event for liquidity.
Positives
- Performance share units vested at 200% of the granted amount, indicating HCA Healthcare successfully exceeded its cumulative earnings per share goal for fiscal years 2023-2025.
Negatives
- A senior executive sold 4,000 shares of common stock, which reduces their direct ownership in the company.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance.
Industry Context
StockSavvy.ai notes that insider sales, particularly following the vesting of equity awards, are a common occurrence for executives seeking liquidity or to cover tax obligations. The 200% vesting indicates strong past performance relative to internal targets, which is generally viewed positively within the healthcare services industry.
Stakeholder Impact
- Shareholders may view the 200% vesting of performance share units as a positive indicator of the company's strong financial performance and management's ability to meet strategic goals.
Key Dates
| Date | Description |
|---|---|
| 01/30/2023 | Date performance share units were granted to the reporting person. |
| 02/10/2026 | Date of acquisition of 3,350 common shares due to PSU vesting and disposition of 1,034 shares for tax withholding. |
| 02/11/2026 | Date of sale of 4,000 common shares by the reporting person. |
| 02/12/2026 | Date the Form 4 filing was signed. |
Recommendation
holdThe vesting of performance share units at 200% indicates strong past financial performance by HCA Healthcare, specifically exceeding its EPS goals. However, the subsequent sale of shares by an executive is a common event for liquidity or tax purposes and does not necessarily signal a change in the company's fundamental outlook. Without additional context on the company's current valuation or future prospects, the filing alone suggests maintaining current positions.
Keywords
HCA Healthcare, HCA, Form 4, insider trading, stock sale, performance share units, executive compensation, Christopher F. Wyatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.